Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Prevalence of gastroduodenal ulcers/erosions in patients taking low-dose aspirin with either 15 mg/day of lansoprazole or 40 mg/day of famotidine: the OITA-GF study 2.

Tamura A, Murakami K, Kadota J; OITA-GF Study 2 Investigators.

BMC Res Notes. 2013 Mar 26;6:116. doi: 10.1186/1756-0500-6-116.

2.

Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin.

Takeuchi T, Ota K, Harada S, Kojima Y, Inoue T, Iwakiri R, Sakata Y, Fujimoto K, Fujita T, Azuma T, Higuchi K.

J Gastroenterol Hepatol. 2014 Dec;29 Suppl 4:11-5. doi: 10.1111/jgh.12768.

PMID:
25521726
3.

Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.

Ng FH, Wong SY, Lam KF, Chu WM, Chan P, Ling YH, Kng C, Yuen WC, Lau YK, Kwan A, Wong BC.

Gastroenterology. 2010 Jan;138(1):82-8. doi: 10.1053/j.gastro.2009.09.063. Epub 2009 Nov 11.

PMID:
19837071
4.

Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.

Chen WC, Li YD, Chiang PH, Tsay FW, Chan HH, Tsai WL, Tsai TJ, Wang EM, Cheng JS, Lai KH.

Biomed Res Int. 2014;2014:693567. doi: 10.1155/2014/693567. Epub 2014 Sep 11.

5.

Preventive effects of lansoprazole and famotidine on gastric mucosal injury induced by low-dose aspirin in Helicobacter pylori-negative healthy volunteers.

Nishino M, Sugimoto M, Kodaira C, Yamade M, Uotani T, Shirai N, Ikuma M, Tanaka T, Sugimura H, Hishida A, Furuta T.

J Clin Pharmacol. 2011 Jul;51(7):1079-86. doi: 10.1177/0091270010376194. Epub 2010 Jul 27.

PMID:
20663999
6.

Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.

Tamura A, Murakami K, Kadota J; OITA-GF Study Investigators.

QJM. 2011 Feb;104(2):133-9. doi: 10.1093/qjmed/hcq169. Epub 2010 Sep 24.

7.

Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.

Tamura I, Fujita T, Tsumura H, Morita Y, Yoshida M, Toyonaga T, Hirano S, Inokuchi H, Kutsumi H, Azuma T.

Intern Med. 2010;49(23):2537-45. Epub 2010 Dec 1.

8.

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.

Taha AS, McCloskey C, Prasad R, Bezlyak V.

Lancet. 2009 Jul 11;374(9684):119-25. doi: 10.1016/S0140-6736(09)61246-0. Epub 2009 Jul 3.

PMID:
19577798
9.

Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.

Miyake K, Ueki N, Suzuki K, Shinji Y, Kusunoki M, Hiratsuka T, Nishigaki H, Tatsuguchi A, Futagami S, Wada K, Tsukui T, Nakajima A, Yoshino S, Sakamoto C.

Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:67-72.

10.
11.

Predictors of gastroduodenal erosions in patients taking low-dose aspirin.

Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson AB, Yeomans ND.

Aliment Pharmacol Ther. 2010 Jan;31(1):143-9. doi: 10.1111/j.1365-2036.2009.04133.x. Epub .

12.
13.

Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury.

Ito Y, Sasaki M, Noguchi S, Yamaguchi S, Okaniwa N, Tanabe A, Noda H, Yanamoto K, Tamura Y, Kondo Y, Masui R, Izawa S, Iida A, Mizuno M, Ogasawara N, Funaki Y, Kasugai K.

United European Gastroenterol J. 2013 Aug;1(4):259-64. doi: 10.1177/2050640613491254.

14.

Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.

Nema H, Kato M.

J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S119-21. doi: 10.1111/j.1440-1746.2010.06229.x.

PMID:
20586852
15.

Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial.

Sanuki T, Fujita T, Kutsumi H, Hayakumo T, Yoshida S, Inokuchi H, Murakami M, Matsubara Y, Kuwayama H, Kawai T, Miyaji H, Fujisawa T, Terao S, Yamazaki Y, Azuma T; Care Study Group.

J Gastroenterol. 2012 Nov;47(11):1186-97. doi: 10.1007/s00535-012-0588-x. Epub 2012 Apr 17.

PMID:
22526273
16.

Assessing the efficacy of famotidine and rebamipide in the treatment of gastric mucosal lesions in patients receiving long-term NSAID therapy (FORCE--famotidine or rebamipide in comparison by endoscopy).

Yamao J, Kikuchi E, Matsumoto M, Nakayama M, Ann T, Kojima H, Mitoro A, Yoshida M, Yoshikawa M, Yajima H, Miyauchi Y, Ono H, Akiyama K, Sakurai G, Kinoshita Y, Haruma K, Takakura Y, Fukui H.

J Gastroenterol. 2006 Dec;41(12):1178-85. Epub 2007 Feb 6.

PMID:
17287897
17.

Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.

Uemura N, Sugano K, Hiraishi H, Shimada K, Goto S, Uchiyama S, Okada Y, Origasa H, Ikeda Y; MAGIC Study Group.

J Gastroenterol. 2014 May;49(5):814-24. doi: 10.1007/s00535-013-0839-5. Epub 2013 Jun 12.

18.

Clinical features of gastroduodenal ulcer in Japanese patients taking low-dose aspirin.

Iwamoto J, Mizokami Y, Shimokobe K, Ito M, Hirayama T, Saito Y, Ikegami T, Honda A, Matsuzaki Y.

Dig Dis Sci. 2010 Aug;55(8):2270-4. doi: 10.1007/s10620-009-1009-8. Epub 2009 Nov 20.

PMID:
19936921
19.

Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.

Goldstein JL, Cryer B, Amer F, Hunt B.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1167-74.

PMID:
17916545
20.

Prevalence of erosive esophagitis among Japanese patients taking low-dose aspirin.

Yamamoto T, Mishina Y, Ebato T, Isono A, Abe K, Hattori K, Ishii T, Kuyama Y.

J Gastroenterol Hepatol. 2010 Apr;25(4):792-4. doi: 10.1111/j.1440-1746.2009.06105.x. Epub 2010 Jan 13.

PMID:
20074160
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk